AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsHealth Care
Dopaminergic NeuronsNeuronsDopamineMesencephalonSubstantia NigraTyrosine 3-MonooxygenaseParkinson DiseaseOxidopamine1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineParkinsonian DisordersCorpus StriatumNeurons, AfferentMPTP Poisoning1-Methyl-4-phenylpyridiniumDopamine AgentsVentral Tegmental AreaNuclear Receptor Subfamily 4, Group A, Member 2Motor Neuronsalpha-SynucleinReceptors, DopamineDopamine Plasma Membrane Transport ProteinsParkinson Disease, SecondaryNerve DegenerationReceptors, Dopamine D2Dopamine AntagonistsDopamine AgonistsNerve Tissue ProteinsLevodopa3,4-Dihydroxyphenylacetic AcidAction PotentialsRats, Sprague-DawleyBrainRotenoneCells, CulturedNeuroprotective AgentsImmunohistochemistryNeostriatumReceptors, Dopamine D1Mice, Inbred C57BLAdrenergic AgentsVesicular Monoamine Transport Proteinsgamma-Aminobutyric AcidBehavior, AnimalGlial Cell Line-Derived Neurotrophic FactorApomorphineGABAergic NeuronsNeurotoxinsParaquatRats, WistarSynaptic TransmissionDisease Models, AnimalSulpirideTegmentum MesencephaliCell DeathDiencephalonCell CountPatch-Clamp TechniquesQuinpiroleAnimals, NewbornElectrophysiologyAxonsDendritesMicrogliaHomovanillic AcidAntiparkinson AgentsSynucleinsCholinergic NeuronsElectric StimulationMice, TransgenicSynapsesLewy BodiesMice, KnockoutTime FactorsBenzazepinesHaloperidolNeural InhibitionNerve Growth FactorsMotor ActivityDose-Response Relationship, DrugHippocampusCell DifferentiationCerebral CortexBrain Tissue TransplantationHerbicidesBasal GangliaSerotoninAnalysis of VarianceMembrane PotentialsReceptors, Dopamine D3Cell Survival2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepineNeurogenesisAmphetamineModels, NeurologicalAnimals, Genetically ModifiedNeurogliaFetal Tissue TransplantationGreen Fluorescent ProteinsDihydroxyphenylalaninePresynaptic Terminals

Estrogenic regulation of dopaminergic neurons in the opportunistically breeding zebra finch. (17/670)

 (+info)

Dopamine system dysregulation by the hippocampus: implications for the pathophysiology and treatment of schizophrenia. (18/670)

 (+info)

Distinct cellular properties of identified dopaminergic and GABAergic neurons in the mouse ventral tegmental area. (19/670)

 (+info)

MPP(+)-induced toxicity in the presence of dopamine is mediated by COX-2 through oxidative stress. (20/670)

 (+info)

The mechanism of ethanol action on midbrain dopaminergic neuron firing: a dynamic-clamp study of the role of I(h) and GABAergic synaptic integration. (21/670)

 (+info)

Novel variant Pro143Ala in HTRA2 contributes to Parkinson's disease by inducing hyperphosphorylation of HTRA2 protein in mitochondria. (22/670)

 (+info)

Mitochondrial ATP-sensitive potassium channels enhance angiotensin-induced oxidative damage and dopaminergic neuron degeneration. Relevance for aging-associated susceptibility to Parkinson's disease. (23/670)

 (+info)

Smoke extracts and nicotine, but not tobacco extracts, potentiate firing and burst activity of ventral tegmental area dopaminergic neurons in mice. (24/670)

 (+info)